A Study to Establish Safety and Maximum Tolerated Dose of IV Trehalose in Healthy Subjects

NCT02725957 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer Subjects

Interventions

DRUG: Trehalose for IV Infusion
DRUG: Saline 0.9% IV

Sponsor

Bioblast Pharma Ltd.

Collaborators

[object Object]